Network origin in Philippe Billiald first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 18 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Philippe Billiald via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Minka Therapeutics SA
Minka Therapeutics SA Pharmaceuticals: MajorHealth Technology Minka Therapeutics SA develops therapeutic products and diagnostic complementary to current antiretroviral therapy in the treatment of AIDS. The firm provides therapeutic and diagnostic solutions for diseases linked to the immune system through its research on immune dysregulations. The company was founded by Patrice Debre, Vincent Vieillard, Michel Klein, Joël Crouzet, and Robert L. Murphy in 2008 and is headquartered in Evry, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Eyevensys SAS
Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
VALERIO THERAPEUTICS | Pharmaceuticals: Major | Founder Director/Board Member | |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SANOFI | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Ncardia SA
Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ATON | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
VOLUNTIS S.A. | Packaged Software | Director/Board Member Director/Board Member | |
Hemarina SA
Hemarina SA BiotechnologyHealth Technology Hemarina SA operates as a biotechnology company which develops oxygen carrier for therapeutic and industrial applications. It offers organ preservation, wound healing, hemoglobin oxygen-carrier, cell culture and bioproduction and other perspective products. The company was founded by Franck Zal, Elisabeth Leize, Morgane Rousselot and Laurent Meijer on March 26, 2007 and is headquartered in Morlaix, France. | Biotechnology | Chairman | |
Centre Hospitalier Universitaire de Liege | College/University | Doctorate Degree | |
Guy Heynen Consulting | Chief Executive Officer | ||
Creativenture SA
Creativenture SA Food DistributorsDistribution Services Creativenture SA produces and markets wines. It provides its products through Custom Wines, Gusto World and Courage Trading. The company is headquartered in Alleur, Belgium | Food Distributors | President | |
NeuVasQ Biotechnologies SA
NeuVasQ Biotechnologies SA Pharmaceuticals: MajorHealth Technology NeuVasQ Biotechnologies SA develops pharmaceutical products to treat neurological disorders by repairing neurovascular function. The company is based in Gosselies, Belgium. The Belgian company was founded in 2021 by Benoit Vanhollebeke. | Pharmaceuticals: Major | Director/Board Member | |
DIM3 SA
DIM3 SA Packaged SoftwareTechnology Services DIM3 SA develops decision support application software and medical devices. The firm offers Scorso, an app for the screening and follow-up of disease-related malnutrition; Nutrow, a decision support software for an optimization of clinical nutrition; and Biocorder, a connected clinical mobile assistant. The company was founded by Jean Claude Havaux on September 23, 2004 and is headquartered in Liege, Belgium. | Packaged Software | Director/Board Member | |
AbolerIS Pharma
AbolerIS Pharma Pharmaceuticals: MajorHealth Technology AbolerIS Pharma develops therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune, and degenerative diseases. The company was founded by Carole Guillonneau, Ignacio Anegon and François-Xavier Hubert and is headquartered in Nantes, France. | Pharmaceuticals: Major | Director/Board Member | |
Adipopharma
Adipopharma Miscellaneous Commercial ServicesCommercial Services Adipopharma is a French biotech company that focuses on developing treatments for insulin resistance, type 2 diabetes, and related conditions. | Miscellaneous Commercial Services | Director/Board Member | |
The Foundation Fighting Blindness, Inc.
The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services The Foundation Fighting Blindness, Inc. provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome. The firm also provides provide information on retinal degenerative diseases to all who request it, in order to increase knowledge and awareness of these diseases. It has locations in Columbia, Denver, Libertyville, New York, Plano, Raleigh and Santa Monica. The company was founded on September 16, 1971 and is headquartered in Columbia, MD. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Financial Conglomerates | Chief Executive Officer | |
Anbics AG | Chief Tech/Sci/R&D Officer | ||
Istituto Gentili Srl
Istituto Gentili Srl Pharmaceuticals: MajorHealth Technology Istituto Gentili Srl is an Italian pharmaceutical company specializing in the oncological and onco-hematological field, and also partners with other companies. The private company is based in Milan, Italy. The company is committed to supporting non-profit associations that focus on solidarity and welcoming, particularly for the protection of children. The company was founded in 1917 by Alfredo Gentili, and the CEO is Alessandro del Bono. | Pharmaceuticals: Major | Chairman | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
A Q Invest SRL | Corporate Officer/Principal | ||
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Founder | |
Vesalius Biocapital II Partners SARL | Founder | ||
Bio-Sourcing SA
Bio-Sourcing SA BiotechnologyHealth Technology Bio-Sourcing SA develops and markets biological drugs for veterinary use. The firm focuses on farm animal health and companion animal health. The company was founded by Bertrand Mérot in June 2011 and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member | |
Université Catholique de Louvain | College/University | Graduate Degree | |
Solvay Business School of Economics & Management | College/University | Undergraduate Degree | |
AQ Partners SRL | Corporate Officer/Principal | ||
Cellaïon SA
Cellaïon SA BiotechnologyHealth Technology Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Pfizer AG | Chief Tech/Sci/R&D Officer | ||
Ncardia Holding SA
Ncardia Holding SA BiotechnologyHealth Technology Ncardia Holding SA provides biotech research and development, business management consulting, technical testing, and administrative services. The private company is based in Mont-Saint-Guibert, Belgium. The Belgian company was founded in 2014. Stefan Braam has been the CEO of the company since 2015. | Biotechnology | Director/Board Member | |
Mediolanum Farmaceutici SpA
Mediolanum Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Mediolanum Farmaceutici SpA engages in the manufacture and distribution of pharmaceutical and therapeutic medicines. Its products include Antoven, Adronat, Budexan, Cechio, and Genalen. The firm provides medical research and development programs. The company was founded by Rinaldo del Bono in 1972 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Founder | |
Laboratoires Leurquin Mediolanum SA
Laboratoires Leurquin Mediolanum SA Pharmaceuticals: MajorHealth Technology Part of Mediolanum Farmaceutici SpA, Laboratoires Leurquin Mediolanum SA is a pharmaceutical company based in Neuilly-sur-Marne, France. The French company is led by CEOs Valerie Guibergia and Patrice Mauriac. | Pharmaceuticals: Major | Chairman | |
Cristalfarma Srl
Cristalfarma Srl Pharmaceuticals: MajorHealth Technology Part of Mediolanum Farmaceutici SpA, Cristalfarma Srl produces pharmaceutical products. The company is based in Milan, Italy and was founded in 2004. | Pharmaceuticals: Major | Chairman | |
DEINOVE | Biotechnology | Chief Tech/Sci/R&D Officer | |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Corporate Officer/Principal | |
CROSSJECT | Medical Specialties | Director/Board Member | |
PHAXIAM THERAPEUTICS S.A. | Pharmaceuticals: Major | Director/Board Member | |
University of Bristol | College/University | Undergraduate Degree | |
DESTINY PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
Grant Thornton SA
Grant Thornton SA Miscellaneous Commercial ServicesCommercial Services Grant Thornton SA engages in the provision of accounting and consulting services. It offers solutions in audit, financial advisory, tax, international business advisory, and outsourcing. The company was founded in 1963 and is headquartered in Neuilly-sur-Seine, France. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
London Business School | College/University | Masters Business Admin | |
Agile Capital Markets SAS | Chief Executive Officer |
Statistics
International
France | 19 |
Belgium | 18 |
United States | 5 |
Switzerland | 4 |
Italy | 4 |
Sectoral
Health Technology | 27 |
Commercial Services | 8 |
Consumer Services | 7 |
Technology Services | 3 |
Distribution Services | 2 |
Operational
Director/Board Member | 95 |
Corporate Officer/Principal | 31 |
Independent Dir/Board Member | 14 |
Chief Tech/Sci/R&D Officer | 13 |
Chairman | 9 |
Most connected contacts
Insiders | |
---|---|
Alain Munoz | 38 |
Alain Parthoens | 29 |
Catherine Boule | 18 |
Guy Heynen | 17 |
Yannick Plétan | 14 |
Gilles Avenard | 11 |
Leila Nicolas | 9 |
Eric Cohen | 6 |
Jean-Pierre Cazenave | 6 |
Patricia Zilliox | 5 |
Rinaldo del Bono | 5 |
Sophie Binay | 4 |
James Stearns | 4 |
Aymeric Humblot | 2 |
Jessica Jami | 1 |
- Stock Market
- Insiders
- Philippe Billiald
- Company connections